Related Experiment Video
Updated: Sep 23, 2025

13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
10.8K
Sarcopenia 'made simple' and outcomes from emergency laparotomy
Yan Joyce Ming1,2, Peter Howley3, Merran Holmes1,2
1Department of Surgery, John Hunter Hospital, Newcastle, New South Wales, Australia.
ANZ Journal of Surgery
|May 17, 2022
Summary
Radiological sarcopenia, measured by the psoas muscle area to L3 vertebral body cross-sectional area ratio (PM:L3), significantly predicts mortality in high-risk Emergency Laparotomy (EL) patients. This simple CT-assessed metric shows potential utility in clinical practice.
Area of Science:
- Surgical oncology
- Radiology
- Geriatric medicine
Background:
- Emergency Laparotomy (EL) is a high-risk surgery associated with significant mortality.
- Established risk assessment tools (NELA, P-POSSUM, ACS-NSQIP) are complex and limited in practical application.
- Sarcopenia is linked to adverse surgical outcomes.
Purpose of the Study:
- To investigate the association between radiological sarcopenia and mortality in Australian Emergency Laparotomy patients.
- To evaluate the utility of a simple radiological sarcopenia measure (PM:L3 ratio) as a predictor of mortality.
Main Methods:
- Retrospective analysis of 500 EL patients from four Australian hospitals (2016-2017).
- Measurement of radiological sarcopenia using the psoas muscle area to L3 vertebral body cross-sectional area ratio (PM:L3) from CT scans.
- Follow-up for up to 12 months to assess 30-, 90-, and 365-day mortality.
Main Results:
- The PM:L3 ratio was significantly associated with 30-, 90-, and 365-day mortality (P < 0.001).
- Radiological sarcopenia showed a weak negative correlation with established risk scores (NELA, P-POSSUM, ACS-NSQIP).
- Established risk assessment tools were significantly correlated with each other.
Conclusions:
- CT-assessed radiological sarcopenia (PM:L3) is a significant predictor of mortality in Australian EL patients.
- The PM:L3 metric demonstrates potential equivalence to established, more complex risk assessment tools.
- The easily accessible and potentially automatable PM:L3 metric may offer significant clinical utility.

